HealthQuill Cancer
The US regulator has approved AstraZenecaā€™s blockbuster drug Imfinzi to treat adults with limited-stage cell lung cancer.
Drugs Medical Pharma

AstraZeneca’s drug gets nod to treat limited-stage cell lung cancer patients

The US regulator has approved AstraZenecaā€™s blockbuster drug Imfinzi to treat adults with limited-stage cell lung cancer.

Read More
Abnormal prenatal blood results are indicative of hidden cancers in pregnant women, researchers at the US nationā€™s medical research agency, the National Institutes of Health, found.
Health Medical Pharma Research

Prenatal blood tests may reveal hidden cancers in pregnant women: NIH

Abnormal prenatal blood results are indicative of hidden cancers in pregnant women, researchers at the US nationā€™s medical research agency, the National Institutes.

Read More
Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the French company will invest 300 million euros for a 16% equity.
Drugs Health Pharma

Sanofi to invest $324m in entity with Orano Med for radioligand therapy

Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the.

Read More
Harvard Medical School scientists have designed an artificial intelligence model similar to ChatGPT that detects cancer or predicts a tumourā€™s genetic profile.
Health Medical Pharma

Harvardā€™s ChatGPT-like AI model can predict tumours, detect cancer

Harvard Medical School scientists have designed an artificial intelligence model similar to ChatGPT that detects cancer or predicts a tumourā€™s genetic profile.

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Drugs Health Pharma

GenX faces a higher risk of 17 cancer types than older generation

Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.

Read More
The US requires a warning label on social media platforms as they are significantly associated with ā€œmental health harmsā€ for adolescents, the United States Surgeon General, Dr Vivek Murthy wrote in an op-ed piece in the New York Times.
Climate Drugs Health

Millennials, Gen X are at elevated risk of developing cancer than older generations

HQ Team August 2, 2024:Cancer risk is higher among the younger generation than the older ones, according to a new study. Millennials and.

Read More
https://www.cancer.gov/news-events/press-releases/2024/genetic-factors-predict-x-chromosome-loss
Drugs Health Pharma

Genetic factors may help predict loss of X chromosome in older women

Researchers co-led by the US-based National Cancer Institute have found genetic variants in women that may play a role in promoting abnormal blood.

Read More
AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.
Drugs Health Pharma

AstraZeneca completes $2.4 billion acquisition of Fusion Pharma

AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.

Read More
AstraZeneca plans to build a $1.5 billion facility to make antibody-drug conjugates in Singapore, the company announced in a statement.
Drugs Health Pharma

AstraZeneca plans to build $1.5 billion drug making facility in SingaporeĀ 

HQ Team May 20, 2024: AstraZeneca plans to build a $1.5 billion facility to make antibody-drug conjugates in Singapore, the company announced in.

Read More
Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion.
Drugs Health Pharma

Novartis AG to buy Mariana Oncology for $1 billion to build RLT assets

HQ Team May 2, 2024: Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion..

Read More